Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Sell
38,307
-2,854
-7% -$329K 0.19% 64
2025
Q4
$4.33M Sell
41,161
-1,104
-3% -$104K 0.18% 70
2025
Q3
$3.55M Sell
42,265
-947
-2% -$78K 0.15% 71
2025
Q2
$3.42M Sell
43,212
-1,301
-3% -$103K 0.16% 72
2025
Q1
$4M Sell
44,513
-3,392
-7% -$317K 0.2% 64
2024
Q4
$4.77M Sell
47,905
-2,957
-6% -$305K 0.24% 59
2024
Q3
$5.78M Buy
50,862
+324
+0.6% +$38.5K 0.3% 57
2024
Q2
$6.26M Buy
50,538
+461
+0.9% +$59.4K 0.34% 57
2024
Q1
$6.61M Sell
50,077
-1,393
-3% -$172K 0.37% 58
2023
Q4
$5.61M Sell
51,470
-826
-2% -$85.7K 0.35% 57
2023
Q3
$5.38M Sell
52,296
-1,343
-3% -$145K 0.38% 56
2023
Q2
$6.19M Sell
53,639
-2,130
-4% -$242K 0.43% 58
2023
Q1
$5.93M Sell
55,769
-1,799
-3% -$194K 0.44% 55
2022
Q4
$6.39M Sell
57,568
-3,965
-6% -$405K 0.5% 52
2022
Q3
$5.3M Sell
61,533
-309
-0.5% -$27.6K 0.44% 58
2022
Q2
$5.64M Sell
61,842
-3,985
-6% -$353K 0.45% 57
2022
Q1
$5.4M Sell
65,827
-2,700
-4% -$213K 0.36% 63
2021
Q4
$5.25M Sell
68,527
-28,304
-29% -$2.25M 0.34% 66
2021
Q3
$7.27M Buy
96,831
+23,240
+32% +$1.77M 0.49% 56
2021
Q2
$5.72M Sell
73,591
-5,211
-7% -$388K 0.41% 61
2021
Q1
$5.8M Sell
78,802
-34,668
-31% -$2.56M 0.46% 60
2020
Q4
$8.86M Buy
113,470
+15,345
+16% +$1.17M 0.72% 39
2020
Q3
$7.77M Sell
98,125
-1,896
-2% -$149K 0.78% 37
2020
Q2
$7.38M Sell
100,021
-2,229
-2% -$168K 0.8% 35
2020
Q1
$7.51M Sell
102,250
-3,057
-3% -$240K 0.98% 27
2019
Q4
$9.14M Sell
105,307
-3,062
-3% -$252K 0.95% 28
2019
Q3
$8.71M Sell
108,369
-922
-0.8% -$73.9K 0.98% 27
2019
Q2
$8.74M Sell
109,291
-3,004
-3% -$230K 1% 27
2019
Q1
$8.91M Sell
112,295
-2,384
-2% -$178K 1.05% 25
2018
Q4
$8.36M Sell
114,679
-2,067
-2% -$146K 1.15% 22
2018
Q3
$7.9M Sell
116,746
-6,844
-6% -$436K 0.98% 29
2018
Q2
$7.16M Sell
123,590
-1,203
-1% -$67.9K 0.97% 29
2018
Q1
$6.49M Buy
124,793
+1,884
+2% +$102K 0.87% 33
2017
Q4
$6.6M Buy
122,909
+3,493
+3% +$194K 0.94% 27
2017
Q3
$7.3M Buy
119,416
+842
+0.7% +$51K 1.12% 24
2017
Q2
$7.25M Buy
118,574
+2,816
+2% +$171K 1.2% 22
2017
Q1
$7.02M Buy
115,758
+1,430
+1% +$86.8K 1.19% 23
2016
Q4
$6.42M Sell
114,328
-634
-0.6% -$37.1K 1.12% 23
2016
Q3
$6.85M Buy
114,962
+79
+0.1% +$4.62K 1.25% 21
2016
Q2
$6.31M Buy
114,883
+1,872
+2% +$99.6K 1.19% 21
2016
Q1
$5.71M Buy
113,011
+289
+0.3% +$14.2K 1.15% 19
2015
Q4
$5.68M Buy
112,722
+434
+0.4% +$21.9K 1.2% 18
2015
Q3
$5.29M Buy
112,288
+3,034
+3% +$161K 1.17% 19
2015
Q2
$5.93M Buy
109,254
+3,029
+3% +$170K 1.23% 19
2015
Q1
$5.83M Buy
106,225
+836
+0.8% +$47.3K 1.21% 25
2014
Q4
$5.71M Sell
105,389
-9,037
-8% -$503K 1.21% 19
2014
Q3
$6.47M Sell
114,426
-1,330
-1% -$74.7K 1.4% 15
2014
Q2
$6.39M Sell
115,756
-695
-0.6% -$37.9K 1.37% 16
2014
Q1
$6.31M Buy
116,451
+912
+0.8% +$47.2K 1.39% 16
2013
Q4
$5.52M Sell
115,539
-1,137
-1% -$52K 1.32% 16
2013
Q3
$5.3M Buy
116,676
+414
+0.4% +$18.9K 1.4% 14
2013
Q2
$5.15M Buy
+116,262
New +$5.19M 1.43% 14

Other funds holding MRK

BLB&B Advisors's MRK Position: Q1 2026 in Review

BLB&B Advisors reduced its Merck (MRK) stake by 6.9% in Q1 2026, selling an estimated $329K and leaving 38,307 shares worth $4.61M. The position accounts for 0.19% of the portfolio, ranked #64.

BLB&B Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.14M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • BLB&B Advisors held 38,307 shares of Merck worth $4.61M as of Q1 2026.
  • BLB&B Advisors sold 2,854 Merck shares in Q1 2026, an estimated $329K.
  • Merck made up 0.19% of BLB&B Advisors's portfolio in Q1 2026, its #64 holding.
  • BLB&B Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • BLB&B Advisors's Merck position peaked at $9.14M in Q4 2019.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on BLB&B Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.